Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cannabidiol 25mg/ml oral solution sugar free
0408010AMAAABAB
|
Cannabidiol | Cannabidiol | Central Nervous System | No data available |
|
Cantassium Fructose powder
0904010G0BCAAAA
|
Cantassium Fructose | Fructose | Nutrition and Blood | No data available |
|
Cantil 25mg tablets
0102000R0BBAAAB
|
Cantil | Mepenzolate bromide | Gastro-Intestinal System | No data available |
|
Canusal 200units/2ml patency solution ampoules
0208010P0BBAAAB
|
Canusal | Heparin flushes | Cardiovascular System | No data available |
|
Capastat 1g powder for solution for injection vials
0501090C0BBAAAA
|
Capastat | Capreomycin | Infections | No data available |
|
Capecitabine 300mg tablets
0801030V0AAACAC
|
Capecitabine | Capecitabine | Malignant Disease and Immunosuppression | No data available |
|
Capecitabine 500mg tablets
0801030V0AAAAAA
|
Capecitabine | Capecitabine | Malignant Disease and Immunosuppression | No data available |
|
Capexion 0.5mg capsules
0802020T0BHAAAF
|
Capexion | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Capexion 1mg capsules
0802020T0BHABAB
|
Capexion | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Capexion 5mg capsules
0802020T0BHACAA
|
Capexion | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Caplenal 100mg tablets
1001040C0BDAAAA
|
Caplenal | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Caplenal 300mg tablets
1001040C0BDABAB
|
Caplenal | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Capoten 12.5mg tablets
0205051F0BCADAD
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 25mg tablets
0205051F0BCABAE
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 50mg tablets
0205051F0BCACAF
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capoten 5mg/ml oral solution
0205051F0BCAFCT
|
Capoten | Captopril | Cardiovascular System | No data available |
|
Capozide 25mg/50mg tablets
0205051G0BCAAAA
|
Capozide | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
Capozide LS 12.5mg/25mg tablets
0205051G0BCABAB
|
Capozide | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
Caprelsa 100mg tablets
0801050BGBBAAAA
|
Caprelsa | Vandetanib | Malignant Disease and Immunosuppression | No data available |
|
Caprelsa 300mg tablets
0801050BGBBABAB
|
Caprelsa | Vandetanib | Malignant Disease and Immunosuppression | No data available |
|
Capreomycin 1g powder for solution for injection vials
0501090C0AAAAAA
|
Capreomycin | Capreomycin | Infections | No data available |
|
Caprilon powder
090401000BBHRA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
Caprin 300mg gastro-resistant tablets
0407010B0BBABA3
|
Caprin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Caprin 75mg gastro-resistant tablets
0209000A0BIAAAK
|
Caprin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Capsaicin 0.006% cream
1003020AAAAACAC
|
Capsaicin | Capsaicin | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.